Andrea Chiesi

Direttore R&D Portfolio Management Chiesi Farmaceutici

05/10/2016  
 
Director R&D Portfolio Management of Chiesi Group.
The role entails the coordination of the planning activities of the projects from the Chiesi R&D, contributing to the definition of the R&D strategic plan and yearly budget, tracking of costs, activities and timelines of projects.
The role also involves the search and management of public grants to R&D projects, and the scientific information & intelligence gathering and diffusion.
Started as a bench analyst in the galenic department in 1993, I have then become a project leader and then a manager of the R&D, leading several reorganisation projects and products developments.VP and co-founder of Advanced Therapies Holostem Ltd., a spin-off of the University of Modena and Reggio Emilia and the Chiesi Group, specialised in the development and manufacturing of advanced therapies, with a particular emphasis on epithelia. The company’s first product, Holoclar®, has been approved last February as the first ever stem-cell based pharmaceutical product in Europe

Buyer e showroom: okay alla transizione graduale

Rivoluzionare ritmi che sono radicati da cinquant’anni in risposta…

Milano vetrina del sistema moda

Al via le sfilate. Sei giorni di eventi all’insegna di un cauto…

I big crescono piu' della manifattura

Le aziende italiane della moda procedono a passo spedito e vantano fondamentali…

Uno sforzo a sostegno del «formato» per competere

Più che del can-can mediatico sulla rivoluzione copernicana delle…